ADAP - Adaptimmune files for $400M mixed shelf offering; shares down 5% after hours

Adaptimmune Therapeutics (NASDAQ:ADAP) has filed for a $400M mixed shelf offering. Shares are down 5% in after-hours trading. The filing does not necessarily indicate that a sale has begun, or will occur in the future. The company will outline the use of proceeds in a prospectus supplement. The offering can include American Depository Shares representing ordinary shares, warrants, and units. Seeking Alpha contributor Avisol Capital Partners views Adaptimmune (ADAP) as a hold.

For further details see:

Adaptimmune files for $400M mixed shelf offering; shares down 5% after hours